Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Prepair 1000+

Gene: ALG2

Red List (low evidence)

ALG2 (ALG2, alpha-1,3/1,6-mannosyltransferase)
EnsemblGeneIds (GRCh38): ENSG00000119523
EnsemblGeneIds (GRCh37): ENSG00000119523
OMIM: 607905, Gene2Phenotype
ALG2 is in 10 panels

3 reviews

Lana Giameos (Victorian Clinical Genetics Services)

I don't know

HGNC approved symbol/name: ALG2
Phenotype(s) are severe and age of onset <18 years old

Association with CMS:
Two families reported (PMID 24461433 and 23404334), same variant identified in both families, likely founder variant.
Proband with pronounced truncal hypotonia, proximal muscle weakness and feeding difficulties at birth (PMID 34980536)

Association with CDG:
One individual with CDG, compound heterozygous, presented in 1st year of life with intellectual disability, seizures, coloboma of the iris, hypomyelination, hepatomegaly, and coagulation abnormalities (PMID: 12684507)
3 probands (including a sibling pair) from 2 families from the same region affected with CDG (PMID: 33644825 and 30397276), presenting with severe neurological and neuro-developmental disorders. This paper cites up to nine ALG2-CDG patients have been reported worldwide.

Model to explore effect of ALG2 gene variants on embryonic development showed abnormalities in embryos with ALG2 variants, and phenotype rescue with injection of mRNA (PMID: 34106226)
Created: 22 Aug 2024, 6:51 a.m. | Last Modified: 22 Aug 2024, 6:51 a.m.
Panel Version: 1.236

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Congenital disorder of glycosylation, type Ii, MIM# 607906; Myasthenic syndrome, congenital, 14, MIM# 616228

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Red List (low evidence)

Insufficient evidence for gene-disease association to be included in a screening panel.
Created: 22 Jun 2022, 2:39 a.m. | Last Modified: 22 Jun 2022, 2:39 a.m.
Panel Version: 0.1

Crystle Lee (Victorian Clinical Genetics Services)

I don't know

One additional variant reported in association with CDG on top of the previously reviewed patients reported with CDG/congenital myasthenia

PMID: 33644825: R251L reported in 3 probands from 2 families with CDG (same patients in PMID: 30397276)
Created: 11 Jul 2022, 7:05 a.m. | Last Modified: 11 Jul 2022, 7:05 a.m.
Panel Version: 0.31
Amber in Mendeliome. For removal from this gene list.

Association with myasthenia: Two families reported, same, likely founder variant.

Association with CDG: one individual with multisystemic disorder with ID, seizures, coloboma of the iris, hypomyelination, hepatomegaly, and coagulation abnormalities reported in PMID 12684507. Fibroblasts showed severely reduced enzymatic activity.
Created: 7 Jun 2022, 11:36 p.m. | Last Modified: 7 Jun 2022, 11:36 p.m.
Panel Version: 0.0

Phenotypes
Myasthenic syndrome, congenital, 14, with tubular aggregates, MIM# 616228; Congenital disorder of glycosylation, type Ii, MIM# 607906

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Red
  • Mackenzie's Mission
Phenotypes
  • Myasthenic syndrome, congenital, 14, with tubular aggregates, MIM# 616228
  • Congenital disorder of glycosylation, type Ii, MIM# 607906
OMIM
607905
Clinvar variants
Variants in ALG2
Penetrance
None
Publications
Panels with this gene

History Filter Activity

22 Jun 2022, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: alg2 has been classified as Red List (Low Evidence).

22 Jun 2022, Gel status: 1

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: ALG2 were changed from Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3) to Myasthenic syndrome, congenital, 14, with tubular aggregates, MIM# 616228; Congenital disorder of glycosylation, type Ii, MIM# 607906

22 Jun 2022, Gel status: 1

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: ALG2 were set to

22 Jun 2022, Gel status: 1

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: alg2 has been classified as Red List (Low Evidence).

1 Jun 2022, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: ALG2 was added gene: ALG2 was added to Reproductive Carrier Screen_VCGS. Sources: Mackenzie's Mission,Expert Review Green Mode of inheritance for gene: ALG2 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: ALG2 were set to Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)